atrasentan has been researched along with Weight Gain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakris, GL; Correa-Rotter, R; de Zeeuw, D; Heerspink, HJL; Hou, FF; Januzzi, JL; Kitzman, DW; Kohan, DE; Kolansky, DM; Koomen, J; Makino, H; McMurray, JJV; Parving, HH; Perkovic, V; Smeijer, JD; Tobe, S | 1 |
| Andress, D; Brennan, JJ; Busch, R; Coll, B; Correa-Rotter, R; de Zeeuw, D; Heerspink, HJL; Houser, M; Kohan, D; Makino, H; Parving, HH; Pergola, P; Perkovic, V; Pritchett, Y; Remuzzi, G; Tobe, SW; Toto, R; Webb, DJ | 1 |
| Andress, D; Brennan, JJ; Coll, B; Correa-Rotter, R; de Zeeuw, D; Hou, FF; Kitzman, DW; Kohan, DE; Lambers Heerspink, HJ; Makino, H; Parving, HH; Perkovic, V; Remuzzi, G; Tobe, SW; Toto, R | 1 |
| Andress, D; Brennan, JJ; Coll, B; Correa-Rotter, R; Davis, JW; de Zeeuw, D; Heerspink, HJ; Idler, K; Kohan, DE; Liu, M; Makino, H; Parving, HH; Perkovic, V; Remuzzi, G; Tobe, SW; Toto, R | 1 |
| Hasegawa, Y; Kawanishi, H; Matsumura, Y; Nakano, D; Ohkita, M; Ohno, Y; Takaoka, M | 1 |
4 trial(s) available for atrasentan and Weight Gain
| Article | Year |
|---|---|
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure.
Topics: Atrasentan; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Natriuretic Peptide, Brain; Renal Insufficiency, Chronic; Weight Gain | 2022 |
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Aged; Atrasentan; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Edema; Electric Impedance; Endothelin Receptor Antagonists; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pyrrolidines; Renin-Angiotensin System; Weight Gain | 2017 |
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy.
Topics: Aged; Albuminuria; Atrasentan; Body Fluids; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Endothelin Receptor Antagonists; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrrolidines; Weight Gain | 2015 |
Comparison of exposure response relationship of atrasentan between North American and Asian populations.
Topics: Aged; Albuminuria; Asia; Asian People; Atrasentan; Bilirubin; Body Fluids; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Female; Humans; Male; Middle Aged; North America; Pyrrolidines; Treatment Outcome; Weight Gain; White People | 2017 |
1 other study(ies) available for atrasentan and Weight Gain
| Article | Year |
|---|---|
Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Topics: Animals; Aorta, Thoracic; Atrasentan; Blood Pressure; Desoxycorticosterone; Dopamine beta-Hydroxylase; Endothelin A Receptor Antagonists; Endothelin-1; Female; Hypertension; Injections, Subcutaneous; Male; Mice; Mice, Knockout; Mice, Transgenic; Organ Size; Ovariectomy; Pyrrolidines; Rats; Receptor, Endothelin B; Sex Factors; Superoxides; Uterus; Weight Gain | 2007 |